ABCL
Price
$3.86
Change
-$0.13 (-3.26%)
Updated
Sep 4, 11:06 AM (EDT)
Capitalization
1.19B
68 days until earnings call
PRME
Price
$3.29
Change
-$0.04 (-1.20%)
Updated
Sep 4, 11:33 AM (EDT)
Capitalization
595.44M
57 days until earnings call
Interact to see
Advertisement

ABCL vs PRME

Header iconABCL vs PRME Comparison
Open Charts ABCL vs PRMEBanner chart's image
AbCellera Biologics
Price$3.86
Change-$0.13 (-3.26%)
Volume$65.66K
Capitalization1.19B
Prime Medicine
Price$3.29
Change-$0.04 (-1.20%)
Volume$100
Capitalization595.44M
ABCL vs PRME Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. PRME commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and PRME is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (ABCL: $3.97 vs. PRME: $3.34)
Brand notoriety: ABCL and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 74% vs. PRME: 53%
Market capitalization -- ABCL: $1.19B vs. PRME: $595.44M
ABCL [@Biotechnology] is valued at $1.19B. PRME’s [@Biotechnology] market capitalization is $595.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than PRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 3 TA indicator(s) are bullish while PRME’s TA Score has 2 bullish TA indicator(s).

  • ABCL’s TA Score: 3 bullish, 5 bearish.
  • PRME’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, both ABCL and PRME are a bad buy in the short-term.

Price Growth

ABCL (@Biotechnology) experienced а -8.62% price change this week, while PRME (@Biotechnology) price change was -2.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.02%. For the same industry, the average monthly price growth was +6.62%, and the average quarterly price growth was +28.65%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 11, 2025.

PRME is expected to report earnings on Oct 31, 2025.

Industries' Descriptions

@Biotechnology (-0.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.19B) has a higher market cap than PRME($595M). ABCL YTD gains are higher at: 35.666 vs. PRME (14.384). PRME (-197.38M) and ABCL (-197.92M) have comparable annual earnings (EBITDA) . ABCL has more cash in the bank: 553M vs. PRME (102M). PRME has less debt than ABCL: PRME (120M) vs ABCL (142M). ABCL has higher revenues than PRME: ABCL (32.9M) vs PRME (4.96M).
ABCLPRMEABCL / PRME
Capitalization1.19B595M200%
EBITDA-197.92M-197.38M100%
Gain YTD35.66614.384248%
P/E RatioN/AN/A-
Revenue32.9M4.96M663%
Total Cash553M102M542%
Total Debt142M120M118%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLPRME
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 7 days ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 14 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 7 days ago
65%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NOINX16.85N/A
N/A
Northern International Equity Index
MSVIX13.30N/A
N/A
MetLife Small Company Equity Inst
MSERX9.69N/A
N/A
MassMutual Small Cap Growth Eq R4
REQSX23.55-0.05
-0.21%
Russell Inv Equity Income C
JSCHX33.73-0.10
-0.30%
JPMorgan Small Cap Blend R6

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with RXRX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-1.85%
RXRX - ABCL
58%
Loosely correlated
-0.64%
CRSP - ABCL
56%
Loosely correlated
+0.61%
VCYT - ABCL
56%
Loosely correlated
+1.69%
ABSI - ABCL
53%
Loosely correlated
+1.50%
BEAM - ABCL
53%
Loosely correlated
+15.02%
More

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
+7.05%
CRSP - PRME
58%
Loosely correlated
+0.61%
RXRX - PRME
54%
Loosely correlated
-0.64%
BEAM - PRME
54%
Loosely correlated
+15.02%
CRBU - PRME
48%
Loosely correlated
+0.53%
NTLA - PRME
46%
Loosely correlated
+2.81%
More